A hepatitis C-vírus szerepe a non-Hodgkin lymphomák kialakulásában

Sulyok Mihály, Makara Mihály, Újhelyi Eszter, Vályi Nagy István

Research output: Article


There is a growing body of evidence for the association between chronic hepatitis C virus infection and certain subtypes of Bcell non-Hodgkin lymphoma. The development of a lymphoid malignancy is usually preceded by cryoglobulinaemia. Here, we summarise the most important epidemiologic data, and the possible molecular mechanisms of HCV-associated lymphomagenesis. The direct oncogenic effect of the virus has not been proven, but chronic antigenic stimulation maintained by replication and viral lymphotropism might both contribute to the development of lymphomas. It should be emphasised that elimination of the hepatitis C virus can halt this process in case of cryoglobulinaemia and low-grade malignity (usually marginal zone lymphomas). In these cases, antiviral therapy might be a useful alternative of conventional immune-chemotherapy. Thus, a collaboration between haematologists and hepatologists might be a great step forward in the treatment of these diseases. It is still not established whether interferon-based short-course therapies and interferon-free regimens are also effective in the treatment of associated lymphomas.

Original languageHungarian
Pages (from-to)88-93
Number of pages6
JournalLege Artis Medicinae
Issue number3
Publication statusPublished - 2014



  • B-lymphocyte
  • Cryoglobulinaemia
  • Hepatitis C
  • Interferon
  • Lymphoma

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Mihály, S., Mihály, M., Eszter, Ú., & István, V. N. (2014). A hepatitis C-vírus szerepe a non-Hodgkin lymphomák kialakulásában. Lege Artis Medicinae, 24(3), 88-93.